Podcast Episodes
Back to Search
Episode 473: Uromigos Shorts - EMBARK and BCR Prostate Cancer
In this podcast, the Brian, Tm and David Einstein discuss the EMBARK study and its implications for patients with biochemically relapsed prostate can…
9 months, 1 week ago
Episode 472: Uromigos Shorts - Variant Histology Bladder Cancer
This podcast discusses the significance of variant histology in urothelial cancer, emphasizing the need for tailored treatment approaches based on hi…
9 months, 2 weeks ago
Episode 471: Uromigos Shorts - ADCs and BiTEs in Prostate Cancer
In this podcast, Brian and Tom engage with Pedro Barata to discuss the emerging field of bispecific T cell engagers and antibody-drug conjugates (ADC…
9 months, 3 weeks ago
Episode 470: Bladder Cancer Year in Review
Tom, Brian and Silke discuss the blockbuster 2025 for urothelial cancer
9 months, 3 weeks ago
Episode 469: Prostate Cancer year in Review
Silke details the 2025 prostate cancer highlights
10 months ago
Episode 468: RCC Year in Review
Brian, Tom and Silke discuss the highlights of RCC for 2025
10 months, 1 week ago
Episode 467: The Uromigos Score for MIBC and Advanced Urothelial Cancer
Matt Galsky joins to discuss the latest iteration of the Uromigos Score in Bladder Cancer. This score quantifies the clinical value of various approa…
10 months, 2 weeks ago
Episode 442: The History of ARPI Development in Prostate Cancer
Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner
11 months ago
Episode 466: #UromigosLive 2025 - Novel Therapy in mRCC
Brian and Tom tag team moderate this session which covers combination data, VEGF/PD1 bispecifics, microbiome approaches, cellular therapy and enrichm…
11 months, 2 weeks ago
Episode 465: #UromigosLive 2025 - Adjuvant Therapy in RCC
Tom leads the panel discussion about this evolving space including the RAMPART data and the press release about pembro/belzu.
11 months, 2 weeks ago